Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Geptanolimab

😃Good
Catalog No. T77023Cas No. 2348469-43-0
Alias Genolimzumab, GB-226, CBT-501, CBT501, APL-501, APL501

Geptanolimab (CBT-501) is a humanized IgG4κ monoclonal antibody directed against PD-1 (Programmed Death-1). Geptanolimab functions by competitively blocking the binding of PD-L1 and PD-L2 to PD-1, thereby reactivating T cell activity. Geptanolimab is under development as an immunotherapeutic agent with potential applications in cancer treatment.

Geptanolimab

Geptanolimab

😃Good
Purity: 95%
Catalog No. T77023Alias Genolimzumab, GB-226, CBT-501, CBT501, APL-501, APL501Cas No. 2348469-43-0
Geptanolimab (CBT-501) is a humanized IgG4κ monoclonal antibody directed against PD-1 (Programmed Death-1). Geptanolimab functions by competitively blocking the binding of PD-L1 and PD-L2 to PD-1, thereby reactivating T cell activity. Geptanolimab is under development as an immunotherapeutic agent with potential applications in cancer treatment.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$198-In Stock
5 mg$578-In Stock
10 mg$913-In Stock
25 mg$1,350-In Stock
50 mg$1,820-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.5% (SDS-PAGE); 97.6% (SEC-HPLC)
Contact us for more batch information

Product Introduction

Bioactivity
Description
Geptanolimab (CBT-501) is a humanized IgG4κ monoclonal antibody directed against PD-1 (Programmed Death-1). Geptanolimab functions by competitively blocking the binding of PD-L1 and PD-L2 to PD-1, thereby reactivating T cell activity. Geptanolimab is under development as an immunotherapeutic agent with potential applications in cancer treatment.
In vitro
Geptanolimab exhibits high specificity in binding to the PD-1 of Homo sapiens (KD=505 pM) and Macaca mulatta (KD=7.2 nM) [1].
Geptanolimab also enhances T-cell activation in mixed lymphocyte response (MLR) of Homo sapiens and significantly increases the release of IL-2 and IFN-γ [1].
In vivo
Geptanolimab was administered via intraperitoneal injection in MC38 syngeneic tumor model mice, demonstrating significant antitumor activity with a tumor inhibition rate as high as 83% [1].
SynonymsGenolimzumab, GB-226, CBT-501, CBT501, APL-501, APL501
Reactivity
Human
Application
Functional assay
Antibody Type
Monoclonal
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetPDCD1/PD-1/CD279
Chemical Properties
Molecular Weight144.14 kDa
Cas No.2348469-43-0
ColorTransparent
AppearanceLiquid
Antibody Information
IsotypeHuman IgG4 kappa
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Geptanolimab | purchase Geptanolimab | Geptanolimab cost | order Geptanolimab | Geptanolimab in vivo | Geptanolimab in vitro | Geptanolimab molecular weight